Glaxosmithkline | Attività Correnti



Current Assets Cambiamento Data
AbbVie USD 25.58B 2.2B 2024-12
Amgen USD 26.93B 2.1B 2025-03
AstraZeneca USD 26.14B 312M 2025-03
Aurora Cannabis CAD 494.21M 76.54M 2024-12
Bausch Health Companies USD 5.73B 42M 2025-03
Bristol-Myers Squibb USD 30.78B 1B 2025-03
Canopy Growth CAD 341.08M 50.58M 2024-12
Corcept Therapeutics USD 471.6M 4.62M 2024-12
Drreddys Laboratories INR 253.02B 4.89B 2024-12
Eli Lilly USD 41.26B 8.52B 2025-03
GlaxoSmithKline GBP 18.08B 1.09B 2025-03
Glaxosmithkline GBP 17B 301M 2024-12
Indivior 883M 44M 2025-03
J&J USD 71.55B 15.66B 2025-03
Merck USD 35.5B 3.28B 2025-03
Novartis USD 29.7B 1.56B 2024-12
Pacira USD 745.13M 55.16M 2024-12
Perrigo USD 2.48B 1.23B 2024-12
Pfizer USD 45.86B 4.5B 2025-03
Prestige Brands USD 377.16M 3.54M 2024-12
Roche Holding CHF 40.04B 6.41B 2024-12
Sanofi 44.02B 1.43B 2025-03
Supernus Pharmaceuticals USD 686.07M 46.07M 2024-12
Takeda JPY 2.75T 299.73B 2024-12
Teva Pharmaceutical Industries USD 12.55B 238M 2024-12
Zoetis USD 5.99B 296M 2024-12



Glaxosmithkline Attività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.